Trial intelligence / Profile preview

Pregabalin as adjunctive therapy in children with partial onset seizures

NCT01389596Phase 3Completed

Sponsor
Viatris
Start
Sep 2011
Primary completion
Aug 2016
Modality
Small Molecules
Countries
18
01

Overview

A Phase 3 trial of pregabalin in focal onset seizure, sponsored by Viatris. Started Sep 2011; status: completed.

02

Drugs

pregabalin
03

Conditions

focal onset seizure

Beyond the preview

Go deeper on NCT01389596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01389596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call